Dose of dialysis: Key lessons from major observational studies and clinical trials

American Journal of Kidney Diseases

Volumn 44, Issue SUPPL. 2, 2004, Pages 47-53

  Saran, Rajiv ^a,b   Canaud, Bernard J ^c   Depner, Thomas A ^d   Keen, Marcia L ^e   McCullough, Keith P ^b   Marshall, Mark R ^f   Port, Friedrich K ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Univ Ren Res and Educ Assoc   (United States)

^c LAPEYRONIE HOSPITAL   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e AMGEN INC   (United States)

^f MIDDLEMORE HOSPITAL   (New Zealand)

Author keywords

clinical trials; Dialysis Outcomes Practice Patterns Study (DOPPS); Hemodialysis dose; Kidney Disease Outcomes Quality Initiative (K DOQI) Guidelines; observational studies

Indexed keywords

UREA;

ARTIFICIAL KIDNEY; CLINICAL TRIAL; DOSIMETRY; HEMODIALYSIS; HEMOFILTRATION; HUMAN; KIDNEY DISEASE; MEMBRANE PERMEABILITY; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; REVIEW; TREATMENT OUTCOME; ULTRAFILTRATION;

EID: 5644241846     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.08.011     Document Type: Article

References (29)

1. U.S. Renal Data System USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health 2003 National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
2. F.A. Gotch, J.A. Sargent A mechanistic analysis of the National Cooperative Dialysis Study (NCDS) Kidney Int 28 1985 526 534
3. F.A. Gotch, N.W. Levin, F.K. Port Clinical outcome relative to the dose of dialysis is not what you think The fallacy of the mean Am J Kidney Dis 30 1997 1 15
4. F.K. Port, V.B. Ashby, R.K. Dhingra Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients J Am Soc Nephrol 13 2002 1061 1066
5. R.A. Wolfe, V.B. Ashby, J.T. Daugirdas Body size, dose of hemodialysis, and mortality Am J Kidney Dis 35 2000 80 88
6. G. Eknoyan, G.J. Beck, A.K. Cheung The Hemodialysis (HEMO) Study Group Effect of dialysis dose and membrane flux in maintenance hemodialysis N Engl J Med 347 2002 2010 2019
7. T. Depner, J. Daugirdas, T. Greene Dialysis dose and the effect of gender and body size on outcome in the HEMO study Kidney Int 65 2004 1386 1394
8. W.F. Owen Jr, G.M. Chertow, J.M. Lazarus Dose of hemodialysis and survival differences by race and sex JAMA 280 1998 1764 1768
9. W.F. Owen Jr, N.L. Lew, Y. Liu The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis N Engl J Med 329 1993 1001 1006
10. A.J. Collins, J.Z. Ma, A. Umen Urea index and other predictors of hemodialysis patient survival Am J Kidney Dis 23 1994 272 282
11. R.M. Hakim, J. Bryer, N. Ismail Effects of dose of dialysis on morbidity and mortality Am J Kidney Dis 23 1994 661 669
12. T.F. Parker 3rd, L. Husni, W. Huang Survival of hemodialysis patients in the United States is improved with greater quantity of dialysis Am J Kidney Dis 23 1994 670 680
13. P.J. Held, F.K. Port, R.A. Wolfe The dose of hemodialysis and patient mortality Kidney Int 50 1996 550 556
14. Z. Li, N.L. Lew, J.M. Lazarus, E.G. Lowrie Comparing the urea reduction ratio and the urea product as outcome-based measures of hemodialysis dose Am J Kidney Dis 35 2000 598 605
15. F.K. Port, S.M. Orzol, P.J. Held Trends in treatment and survival for hemodialysis patients in the United States Am J Kidney Dis 32 suppl 4 1998 S34 S38
16. 2000 Annual Report ESRD Clinical Performance Measures Project 2000 Department of Health and Human Services, Health Care Financing Administration, Office of Clinical Standards and Quality Baltimore, MD: 1 50
17. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy Update 2000 Am J Kidney Dis 37 suppl 1 2001 S7 S64
18. A. Sehgal, R.J. Snow, M.E. Sinder Barriers to adequate delivery of hemodialysis Am J Kidney Dis 31 1998 593 601
19. T.A. Depner How will the results of the HEMO Study impact dialysis practice? Semin Dial 16 2003 8 11
20. F. Locatelli How will results of the HEMO Study impact dialysis practice? Semin Dial 16 2003 20 21
21. F.K. Port, R.A. Wolfe How will results of the HEMO Study impact dialysis practice? Semin Dial 16 2003 13 16
22. F.K. Port, R.L. Pisoni, J.L. Bragg-Gresham DOPPS estimates of patient life years attributable to modifiable hemodialysis treatment practices in the United States Blood Purif 22 2004 175 180
23. F.K. Port, R.A. Wolfe, T.E. Hulbert-Shearon High dialysis dose is associated with lower mortality among women but not among men Am J Kidney Dis 43 2004 1014 1023
24. D.A. Goodkin, J.L. Bragg-Gresham, K.G. Koenig Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States in the Dialysis Outcomes and Practice Patterns Study (DOPPS) J Am Soc Nephrol 14 2003 3270 3277
25. R. Saran, J.L. Bragg-Gresham, C. Combe High ultrafiltration rates are associated with poor outcomes in hemodialysis patients The Dialysis Outcomes and Practice Patterns Study (DOPPS) J Am Soc Nephrol 14 2003 234A (abstr)
26. B. Canaud, J.L. Bragg-Gresham, M.R. Marshall Patients receiving hemodiafiltration or hemofiltration have lower mortality risk than patients receiving hemodialysis without replacement fluid (HD) in Europe The Dialysis Outcomes and Practice Patterns Study (DOPPS) J Am Soc Nephrol 14 2003 31A (abstr)
27. F. Locatelli, T. Hannedouche, S. Jacobson The effect of membrane permeability on ESRD Design a prospective randomized multicentre trial J Nephrol 12 1999 85 88
28. B. Charra, C. Chazot, G. Jean Long 3 × 8 hr dialysis A three-decade summary J Nephrol 16 suppl 7 2003 S64 S69
29. R.M. Lindsay, P.G. Blake How will results of the HEMO Study impact dialysis practice? Semin Dial 16 2003 16 19